SDS Biotech sales up 45% in Q2 2014

The consolidated agchem sales of SDS Biotech in the second quarter of 2014 were increased by 44.6% to yen 6,638 million ($63.3 million at current rate). A positive operating income was posted, which amounted to yen 337 million ($3.2 million). The net income was yen 117 million($1.1 million).

In the first half of 2014, sales rose by 45.1% to yen 11.3 billion ($107.9 million), and operating income and net income grew sharply to yen 742 million ($7.1 million) and yen 327 million ($3.1 million) respectively.   

Sales break down in Q2 2014

Net sales of fungicides in the second quarter were yen 2,169 million (an increase of yen 318 million or up 17.2% year on year). This was primarily due to steady shipments of Daconil products (technical and formulation) and an improvement in the export business on the back of a weaker yen.

Insecticides net sales were yen 958 million (an increase of yen 443 million or up 86.2% year on year). This was mainly thanks to strong sales at our consolidated subsidiary Ramcides in India.

Net sales of paddy herbicides were yen 1,715 million (an increase of yen 586 million or up 52.0% year on year). This was mainly by the virtue of favorable shipments of Benzobicyclon products (technical and formulation) and various products of paddy herbicide technical including Dymron technical and Cafenstrole technical.

Net sales for the Greenery-related products were yen 1,350 million (an increase of yen 403 million or up 42.6% year on year). This was mainly by virtue of strong sales at our consolidated subsidiary Ramcides in India.

Net sales for others were yen 444 million (an increase of yen 295 million or up 197.3% year on year). This was mainly attributable to strong sales of functional fertilizers in India at our consolidated subsidiary Ramcides.